Avantor® to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Avantor, Inc. (NYSE: AVTR) announced that its CEO, Michael Stubblefield, will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference in New York on September 12, 2022, at 4:15 p.m. EDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Avantor, Inc. (NYSE: AVTR) announced that its CEO, Michael Stubblefield, will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference in New York on September 12, 2022, at 4:15 p.m. EDT. The session will be available via a live webcast on Avantor's investor website, with a replay accessible for 90 days post-event. Avantor is a global provider of critical products and services across various industries, serving over 225,000 customers globally.
Details
News Market Reaction – AVTR
The recorded move for AVTR in the trading session of this news was -0.95%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., Aug. 30, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference at the Sheraton New York Hotel in New York on Monday, September 12, at approximately 4:15 p.m. Eastern Daylight Time.
A live webcast can be accessed on the investors section of Avantor's website and a replay will be available for approximately 90 days.
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, please visit www.avantorsciences.com.
Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com
Media Contact
Petro Kacur
Director, PR & External Communications
Avantor
404-408-0663
Petro.Kacur@avantorsciences.com
View original content:https://www.prnewswire.com/news-releases/avantor-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference-301613894.html
SOURCE Avantor and Financial News
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.